West Pharmaceutical Services reported $213.8M in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Align Technology ALGN:US USD 147.12M 71.35M
Atrion ATRI:US USD 14.48M 3.28M
Baxter International BAX:US USD 855M 68M
Becton, Dickinson and BDX:US USD 1.28B 100M
Catalent CTLT:US USD 161M 200M
Charles River Laboratories CRL:US USD 225.58M 38.25M
Cooper Companies COO:US USD 222.3M 3.8M
Dentsply International XRAY:US USD 148M 61M
Icu Medical ICUI:US USD 72.67M 7.47M
Insulet PODD:US USD 18.8M 1000K
Integra Lifesciences IART:US USD 105.32M 2.51M
IQVIA Holdings Inc IQV:US USD 736M 9M
Johnson & Johnson JNJ:US USD 7.81B 876M
Medtronic MDT:US USD 2.25B 247M
Meridian Bioscience VIVO:US USD 13.03M 435K
Merit Medical Systems MMSI:US USD 52.14M 2.03M
Orasure Technologies OSUR:US USD 11.36M 18.33M
Repligen RGEN:US USD 64.54M 6.54M
West Pharmaceutical Services WST:US USD 213.8M 41.8M